Hong Kong Building Stock News

BrainAurora Medical Technology (SEHK:6681) has laid out its FY 2025 scorecard with first half revenue of C¥100.1 million and a basic EPS loss of C¥0.11, alongside net income excluding extra items of a C¥126.4 million loss. The company has seen revenue move from C¥51.9 million in 1H 2024 to C¥70.4 million in 2H 2024 and then to C¥100.1 million in 1H 2025. Trailing twelve month EPS stands at a loss of C¥0.20 on net income excluding extra items of a C¥210.3 million loss, so investors are left...

China MeiDong Auto Holdings (SEHK:1268) has just posted FY 2025 first half results with revenue of C¥10.1b and a basic EPS loss of C¥0.61, keeping the spotlight firmly on profitability and margins. Over the last three reported half year periods, revenue has moved from C¥10.7b in 1H 2024 to C¥11.5b in 2H 2024 and now C¥10.1b in 1H 2025. Over the same periods, basic EPS has shifted from a small loss of C¥0.02 in 1H 2024 to a larger loss of C¥1.66 in 2H 2024 and C¥0.61 in 1H 2025. The current...

Beijing Airdoc Technology (SEHK:2251) has reported its FY 2025 first half with revenue of ¥83.7 million and a basic EPS loss of ¥0.016, while trailing twelve month figures show revenue of ¥146.4 million and a basic EPS loss of ¥1.73. Over recent periods, the company has seen revenue move between ¥93.7 million in 1H 2024 and ¥62.7 million in 2H 2024 alongside net income losses of ¥80.5 million and ¥175.0 million respectively. This underlines that the top line has not yet translated into...

Zhejiang Expressway (SEHK:576) has reported full year 2025 results with fourth quarter revenue of C¥5.6b and basic EPS of C¥0.19, setting the stage for investors to reassess how earnings quality and margins are evolving. Over recent quarters the company has seen revenue range from C¥4.3b to C¥5.6b and quarterly EPS move between C¥0.19 and C¥0.25. Trailing 12 month EPS sits at C¥0.89 on revenue of C¥19.8b and net income of C¥5.3b, so the latest print lands in the context of solid absolute...

Smart-Core Holdings (SEHK:2166) has just put fresh numbers on the table, with first half FY 2025 revenue of HK$2.8b and basic EPS of HK$0.10, set against trailing twelve month EPS of HK$0.35. Over recent periods, the company has seen revenue move from HK$2,623.9m in 1H FY 2024 to HK$2,024.0m in 2H FY 2024 and then to HK$2,796.2m in 1H FY 2025, while basic EPS shifted from HK$0.08 to HK$0.14 and then to HK$0.10. With a trailing net profit margin of 2.4% versus 2.2% a year earlier, investors...

Justin Allen Holdings (SEHK:1425) has opened FY 2025 with first half revenue of HK$362.2 million, net income of HK$30.4 million and basic EPS of HK$0.024, setting a measured tone for its latest results. The company has seen revenue move from HK$385.1 million in 1H 2024 to HK$362.2 million in 1H 2025, while EPS shifted from HK$0.034 to HK$0.024 over the same periods, giving you a clear line of sight on how the top and bottom line are tracking into the new financial year. With a trailing net...

Yuanda China Holdings (SEHK:2789) has reported its FY 2025 first half results with revenue of C¥1.27b and basic EPS of C¥0.029659, while trailing twelve month figures show revenue of C¥2.39b paired with a loss of C¥175.82m on a basic EPS of C¥0.028317. The company has seen revenue move from C¥1.09b in the first half of 2024 to C¥1.27b in the first half of 2025, with basic EPS shifting from C¥0.000962 to C¥0.029659 over the same periods. This latest release serves as a test of how far margins...

Jilin Province Huinan Changlong Bio-pharmacy (SEHK:8049) has posted its FY 2025 first half results with revenue of C¥438.9 million and basic EPS of C¥0.184, set against trailing 12 month revenue of C¥901.9 million and EPS of C¥0.355 that came alongside a 7.9% earnings uplift and net profit margins of 22.1%. Over the past year, the company has seen revenue move between C¥881.2 million and C¥926.9 million on a trailing 12 month basis, with basic EPS ranging from C¥0.327 to C¥0.355. This gives a...

JD Health International (SEHK:6618) is back in focus after CF PharmTech selected the company as its exclusive online launch partner for key respiratory and rhinology drugs over the next three years. See our latest analysis for JD Health International. The CF PharmTech agreement comes as JD Health’s share price sits at HK$48.96, with a 7 day share price return of 2.68% but a 30 day share price return decline of 5.76%. The 1 year total shareholder return of 48.36% contrasts with a 3 year total...

Wuxi Life International Holdings Group (SEHK:8148) has reported its FY 2025 results with first half revenue of HK$28.1 million and basic EPS of HK$0.0048, alongside trailing twelve month revenue of HK$94.6 million and EPS of HK$0.0251 that reflect the shift from loss to profit over the past year. Over the last three first half periods, revenue was HK$13.3 million in 2023, HK$28.8 million in 2024, and HK$28.1 million in 2025. Over the same periods, basic EPS moved from a loss of HK$0.0149 in...

China Qinfa Group (SEHK:866) has reported its FY 2025 first half with revenue of C¥1,089.4 million and basic EPS of C¥0.008, while the trailing twelve months show revenue of about C¥1.8 billion and basic EPS of C¥0.032. Over the past reported periods, revenue has moved from C¥493.4 million in 1H 2024 to C¥1,227.7 million in 2H 2024 and then to C¥1,089.4 million in 1H 2025. Over the same periods, basic EPS shifted from a loss of C¥0.018 in 1H 2024 to C¥0.183 in 2H 2024 and C¥0.008 in the...

Lygend Resources & Technology (SEHK:2245) has reported its FY 2025 first half with revenue of C¥18.1b and basic EPS of C¥0.92, set against a backdrop of 61.1% earnings growth over the last year and a five year compound earnings growth rate of 17.6% per year. The company has seen revenue move from C¥10.9b in 1H 2024 to C¥18.4b in 2H 2024 and then C¥18.1b in 1H 2025, while basic EPS tracked from C¥0.38 to C¥0.76 and then C¥0.92. This leaves investors with a picture of expanding profitability...

China Ruifeng Renewable Energy Holdings (SEHK:527) has reported FY 2025 first half revenue of C¥183.4 million, with EPS of a loss of C¥0.0207 per share. This keeps the focus firmly on how quickly the business is working through its unprofitable patch. Over recent periods, revenue has moved from C¥173.6 million in 1H 2024 to C¥162.7 million in 2H 2024 and C¥183.4 million in 1H 2025, while EPS has ranged from a loss of C¥0.0221 to a loss of C¥0.0567 and then a loss of C¥0.0207. This gives...

Symphony Holdings (SEHK:1223) has released its FY 2025 first half numbers, with revenue at HK$148.2 million and a basic EPS loss of HK$0.0045. The trailing twelve months show revenue of HK$308.8 million and a basic EPS loss of HK$0.0111. Over recent periods, revenue has moved in a tight band between HK$148.2 million and HK$157.2 million per half year, while half yearly basic EPS losses have ranged from HK$0.0045 to HK$0.048. This keeps the focus firmly on how efficiently those sales are being...

Latest FY 2025 Results Snapshot Guangdong - Hong Kong Greater Bay Area Holdings (SEHK:1396) has posted its FY 2025 numbers with first half revenue of CN¥228.3 million and Basic EPS of CN¥1.19, while trailing twelve month revenue stands at CN¥1.0 billion and EPS at CN¥0.08. Over the last year, the company has reported revenue moving from CN¥2.6 billion and EPS of a CN¥3.32 loss in 2024 H2 to CN¥1.0 billion and positive EPS of CN¥0.08 on a trailing basis, marking a clear shift in reported...

Huanxi Media Group (SEHK:1003) has released its FY 2025 results with second half revenue of HK$162.1 million and a basic EPS loss of HK$0.108, against a trailing twelve month revenue base of HK$342.1 million and a TTM EPS loss of HK$0.136. Over recent periods the company has seen revenue move from HK$34.2 million in 2H 2024 to HK$179.9 million in 1H 2025 and HK$162.1 million in 2H 2025, while basic EPS has stayed in loss making territory ranging between HK$0.027 and HK$0.108 per share. With...

China Yongda Automobiles Services Holdings (SEHK:3669) has opened FY 2025 with first half revenue of C¥27.1b and a basic EPS loss of C¥1.78, while trailing twelve month figures show revenue of C¥54.6b and a basic EPS loss of C¥2.72. Over the past three reported half year periods, revenue has moved from C¥31.0b in 1H 2024 to C¥32.4b in 2H 2024, before landing at C¥27.1b in 1H 2025. Basic EPS shifted from profit of C¥0.06 and C¥0.05 in 2024 to a loss of C¥1.78 in the latest half, setting up a...

Qilu Expressway (SEHK:1576) has opened FY 2025 with first half revenue of C¥1,067.4 million and basic EPS of C¥0.10, against a trailing twelve month revenue line of C¥5,281.6 million and EPS of C¥0.21. Over recent reporting periods the company has seen revenue move from C¥2,807.6 million in 1H 2024 to C¥4,214.2 million in 2H 2024, while basic EPS shifted from C¥0.12 to C¥0.11. Investors are left to balance that history with an improving trailing net profit margin of 7.8% versus 6.7% a year...

Guan Chao Holdings (SEHK:1872) has opened FY 2025 with first half revenue of S$140.1 million and a basic EPS loss of S$0.003652, setting the tone for what remains an earnings rebuilding story. The company has seen revenue move from S$80.1 million in 1H 2024 to S$110.8 million in 2H 2024 and then to S$140.1 million in 1H 2025. EPS shifted from a profit of S$0.00743 in 1H 2024 to losses of S$0.037094 in 2H 2024 and S$0.003652 in the latest half, pointing to pressure on margins that keeps...

Radiance Holdings (Group) (SEHK:9993) has reported FY 2025 first half revenue of about C¥6.4b and a basic EPS loss of C¥0.06, with net income excluding extra items at a loss of C¥233.1m, keeping profitability under pressure. The company has seen revenue move from C¥16.4b in 2024 H1 to C¥8.4b in 2024 H2 and then to C¥6.4b in 2025 H1, while basic EPS moved from a loss of C¥0.50 to a loss of C¥1.75 and then a smaller loss of C¥0.06. This sets up a mixed picture for margins and earnings quality...

Chaoju Eye Care Holdings (SEHK:2219) has posted its FY 2025 first half numbers, with revenue of C¥698.3 million and basic EPS of C¥0.16. This helps illustrate how margins are holding up after a softer recent earnings patch. Over the last three reported periods, revenue has moved from C¥734.3 million in 1H 2024 to C¥671.2 million in 2H 2024 and C¥698.3 million in 1H 2025. Over the same timeframe, basic EPS shifted from C¥0.20 to C¥0.08 and then to C¥0.16, giving investors a clearer view of how...

Hongcheng Environmental Technology (SEHK:2265) has reported its FY 2025 first half results with revenue of CNY 133.6 million and basic EPS of CNY 0.036403. This sits against trailing twelve month revenue of CNY 262.4 million and EPS of CNY 0.075969, alongside a 177.1% earnings increase over the past year. The company has seen revenue move from CNY 105.1 million and EPS of CNY 0.020446 in 1H FY 2024 to CNY 128.8 million and EPS of CNY 0.039566 in 2H FY 2024, before reaching current FY 2025...

Latest Earnings Set the Stage for Jiangxi Rimag Group (SEHK:2522) Jiangxi Rimag Group (SEHK:2522) has just reported its FY 2025 first half results, with revenue of C¥467.0 million and basic EPS of C¥0.046, against a backdrop of trailing 12 month revenue of C¥813.9 million and a loss per share of C¥0.093. Over recent periods the company has seen revenue move from C¥413.7 million and EPS of C¥0.011 in 2024 H1 to C¥346.9 million and an EPS loss of C¥0.140 in 2024 H2, before landing at the latest...

Central New Energy Holding Group (SEHK:1735) has opened FY 2025 with first half revenue of HK$4.0b and basic EPS of HK$0.0055, setting a cautious tone around profitability at the current share price of HK$8.28. Over recent periods the company has seen revenue move from HK$2,531.9m in 1H 2024 to HK$3,500.1m in 2H 2024 and then to HK$4,048.9m in 1H 2025. Over the same periods EPS shifted from HK$0.0096 to HK$0.0156 and then HK$0.0055, so the focus now is firmly on how these headline numbers...